Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.0000769 per share
-
Shares outstanding
-
45,504,462
-
Total 13F shares
-
1,905,237
-
Share change
-
-44,842
-
Total reported value
-
$2,363,000
-
Price per share
-
$1.24
-
Number of holders
-
5
-
Value change
-
-$160,746
-
Number of buys
-
2
-
Number of sells
-
3
Institutional Holders of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) as of Q3 2020
As of 30 Sep 2020 Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) had 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,905,237 shares of stock of the company.
Largest 5 holders included Knoll Capital Management, LP, WEDBUSH SECURITIES INC, CITADEL ADVISORS LLC, Phoenix Holdings Ltd., and UBS Group AG.
This table shows 5 institutional shareholders of the security as of 30 Sep 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.